In reply

In reply

Detalhes bibliográficos
Main Authors:	Armitage, J, Clarke, R, Collins, R
Formato:	Journal article
Idioma:	English
Publicado em:	2010

Registos relacionados

Effects of Folic Acid Plus Vitamin B-12 vs Placebo in Myocardial Infarction Survivors Reply
Por: Armitage, J, et al.
Publicado em: (2010)

Safety of long-term simvastatin discontinuation Reply
Por: Bulbulia, R, et al.
Publicado em: (2012)

Lessons from the controversy over statins - Authors' reply.
Por: Armitage, J, et al.
Publicado em: (2016)

Heart Protection Study - Reply
Por: Collins, R, et al.
Publicado em: (2003)

Safety and efficacy of statins - Authors' reply
Por: Collins, R, et al.
Publicado em: (2017)

MRC/BHF Heart Protection Study - Reply
Por: Collins, R, et al.
Publicado em: (2002)

New analyses of Heart Protection Study - Reply
Por: Collins, R, et al.
Publicado em: (2004)

C-reactive protein in the Heart Protection Study - Authors' reply
Por: Emberson, J, et al.
Publicado em: (2011)

C-reactive protein in the Heart Protection Study Reply
Por: Emberson, J, et al.
Publicado em: (2011)

Comments on the MRC/BHF Heart Protection Study - Authors' reply
Por: Collins, R, et al.
Publicado em: (2003)

Regarding "Does simvastatin save lives; If so, when and in whom?" - Reply
Por: Bulbulia, R, et al.
Publicado em: (2008)

Cholesterol, statins, and mortality - Authors' reply
Por: Lewington, S, et al.
Publicado em: (2008)

Cholesterol, statins, and mortality - Reply
Por: Lewington, S, et al.
Publicado em: (2008)

The authors reply
Por: Collins, R, et al.
Publicado em: (2009)

Reply [7]
Por: Hin, H, et al.
Publicado em: (2007)

The authors reply
Por: Farrall, M, et al.
Publicado em: (2010)

ISIS-3 - REPLY
Por: Collins, R, et al.
Publicado em: (1991)

ISIS-4 - REPLY
Por: Collins, R, et al.
Publicado em: (1995)

Whitehall Study Authors' reply
Por: Clarke, R, et al.
Publicado em: (2009)

Authors' reply [5]
Por: Chen, Z, et al.
Publicado em: (2006)

AFTER ISIS-3 - REPLY
Por: Collins, R, et al.
Publicado em: (1992)

Statins and diabetes - Reply
Por: Kearney, P, et al.
Publicado em: (2008)

Unravelling the fetal origins hypothesis - Reply
Por: Huxley, R, et al.
Publicado em: (2002)

Reply
Por: Rider, O, et al.
Publicado em: (2010)

In search of genetic precision - Reply
Por: Keaveny, B, et al.
Publicado em: (2003)

Statins and diabetes - Authors' reply
Por: Kearney, P, et al.
Publicado em: (2008)

PEP trial - Reply
Por: Collins, R, et al.
Publicado em: (2000)

Reply to Arthur Hills
Por: Michael Collins
Publicado em: (2019-11-01)

Lipid fractions and survival in older men - Reply
Por: Clarke, R, et al.
Publicado em: (2008)

TRIALS OF ANTIPLATELET THERAPY - REPLY
Por: Baigent, C, et al.
Publicado em: (1994)

Radiotherapy and surgery in early breast cancer - Reply
Por: Peto, R, et al.
Publicado em: (1996)

Folic acid fortification in the prevention of neural tube defects - Reply
Por: Evans, J, et al.
Publicado em: (2004)

LOW CHOLESTEROL AND CORONARY HEART-DISEASE - REPLY
Por: Chen, Z, et al.
Publicado em: (1991)

Clopidogrel and metoprolol in myocardial infarction - Reply
Por: Chen, Z, et al.
Publicado em: (2006)

Authors' reply to Bird.
Por: Collins, G, et al.
Publicado em: (2012)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
Por: Clarke, R, et al.
Publicado em: (2007)

Interpretation of IST and CAST stroke trials - Reply
Por: Chen, Z, et al.
Publicado em: (1997)

Analyses of Cancer Data from Three Ezetimibe Trials Reply
Por: Collins, R, et al.
Publicado em: (2009)

Portugal, Armitage, Newbold, Drakesmith and Mota reply
Por: Portugal, S, et al.
Publicado em: (2011)

Helicobacter pylori and myocardial infection - Exclusion criteria were inappropriate - Reply
Por: Danesh, J, et al.
Publicado em: (2000)